- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Coenzyme Q10 Pharmacokinetics in United Kingdom
Total 491 results
-
VA Office of Research and DevelopmentCompletedGulf War Illness | Chronic Fatigue | Coenzyme Q10 | UbiquinolUnited States
-
Johns Hopkins UniversityCompletedHealthy Subjects | Cytochrome P450 CYP3A5 Enzyme Polymorphism | Pharmacokinetics of MaravirocUnited States
-
Modern Biosciences LtdRecruitingPharmacokineticsUnited Kingdom
-
Zentiva, k.s.CompletedPharmacokineticsUnited Kingdom
-
Oxford Pharmascience LtdCompleted
-
UCB Biopharma S.P.R.L.CompletedPharmacokineticsUnited Kingdom
-
Prostrakan PharmaceuticalsCompletedPharmacokineticsUnited Kingdom
-
Xspray Pharma ABCompletedPharmacokinetics | BioavailabilityUnited Kingdom
-
Oxford Pharmascience LtdCompleted
-
MediGeneTerminatedPharmacokineticsUnited Kingdom
-
AstraZenecaCompletedPharmacokineticsUnited Kingdom
-
Merckle GmbHCompletedPharmacokinetics | PharmacodynamicsUnited Kingdom
-
Heptares Therapeutics LimitedCompletedBioavailability and PharmacokineticsUnited Kingdom
-
Daiichi Sankyo, Inc.CompletedPharmacokinetics | Tolerability | SafetyUnited Kingdom
-
Rock Creek Pharmaceuticals, Inc.CompletedPharmacokinetics of AnatabineUnited Kingdom
-
Astellas Pharma Europe B.V.CompletedPharmacokinetics of ASP1707United Kingdom
-
AstraZenecaCompletedHealthy Volunteers | PharmacokineticsUnited Kingdom
-
Astellas Pharma IncCompletedHealthy Subjects | Pharmacokinetics | CardiovascularUnited Kingdom
-
Beckley Psytech LimitedCompletedPharmacokinetics in Healthy AdultsUnited Kingdom
-
Beckley Psytech LimitedCompletedPharmacokinetics in Healthy AdultsUnited Kingdom
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Pharmacokinetics | EC905United Kingdom
-
Heptares Therapeutics LimitedCompletedPharmacokinetics | Safety IssuesUnited Kingdom
-
AstraZenecaCompletedSafety, Pharmacokinetics, Pharmacodynamics, Food EffectUnited Kingdom
-
AstraZenecaCompletedPharmacokinetics | Bioequivalence | Healthy Japanese SubjectsUnited Kingdom
-
Astellas Pharma Europe B.V.CompletedHealthy Volunteers | Pharmacokinetics of ASP3700United Kingdom
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Pharmacokinetics of IpragliflozinUnited Kingdom
-
NorgineQuotient SciencesCompleted
-
Gedeon Richter Plc.Completed
-
e-Therapeutics PLCCompletedCancer | Pharmacokinetics | Tolerability | SafetyUnited Kingdom
-
AstraZenecaCompletedHealthy Subjects | Pharmacokinetics | Tolerability | SafetyUnited Kingdom
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Pharmacokinetics of ASP6294United Kingdom
-
Astellas Pharma Europe B.V.TerminatedHealthy Subjects | Pharmacokinetics of ASP2205United Kingdom
-
Astellas Pharma Europe B.V.CompletedHealthy Volunteers | Pharmacokinetics of ASP7962United Kingdom
-
Astellas Pharma Europe B.V.CompletedTolerability | Safety | Pharmacokinetics of ASP7962United Kingdom
-
Xention LtdCompleted
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Pharmacokinetics of ASP3652United Kingdom
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Pharmacokinetics | EC905 | Multiple DoseUnited Kingdom
-
Aegerion Pharmaceuticals, Inc.CompletedIntra-subject Variability of PharmacokineticsUnited Kingdom
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Pharmacokinetics | Pharmacodynamics | Effect of RaceUnited Kingdom
-
Abbott ProductsQuintiles, Inc.Terminated
-
AstraZenecaCompletedHealthy Volunteers Pharmacokinetic StudyUnited Kingdom
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Pharmacokinetics | EC905United Kingdom
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Pharmacokinetics of ASP3652 | Pharmacodynamics of ASP3652United Kingdom
-
AstraZenecaCompletedPharmacokinetic Profile | Plasma ConcentrationUnited Kingdom
-
Astellas Pharma Europe B.V.TerminatedHealthy Subjects | Pharmacokinetics of ASP7657 | Pharmacodynamics of ASP7657United Kingdom
-
University Hospital Birmingham NHS Foundation TrustCompletedPharmacokinetics | General Anaesthesia | Propofol | Target Controlled InfusionUnited Kingdom
-
Jazz PharmaceuticalsCompletedEvaluation of Pharmacokinetics of Sativex in the Absence and Presence of a Known Inducer of CYP3A4 | Evaluation of Pharmacokinetics of Sativex in the Absence and Presence of a Potent Inhibitor of CYP3A4 | Evaluation of Pharmacokinetics of Sativex in the Absence and Presence of a CYP2C19...United Kingdom
-
University of East AngliaUniversity of Washington; Fred Hutchinson Cancer CenterUnknownAn Acute Human Intervention With Flavonoid to Investigate Absorption, Metabolism and Excretion (COB)Pharmacokinetics of Flavonoids in HumansUnited Kingdom
-
Nerre Therapeutics Ltd.CompletedPharmacokinetic Study in Healthy Male VolunteersUnited Kingdom
-
AstraZenecaWithdrawnHealthy Male Subjects | Pharmacokinetics | Safety | Food EffectUnited Kingdom